# High Dose Rate Intracavitary Brachytherapy as the Sole Method of Radiation Therapy for Breast Carcinoma

> **NCT00165581** · NA · TERMINATED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 15 (—)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** High Dose Intracavitary Brachytherapy

## Key facts

- **NCT ID:** NCT00165581
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-12
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 15 (—)
- **Why stopped:** Due to continuing review
- **Last updated:** 2007-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00165581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00165581, "High Dose Rate Intracavitary Brachytherapy as the Sole Method of Radiation Therapy for Breast Carcinoma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00165581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*